BTC $62,539.54 -3.76%
ETH $1,768.21 -2.95%
BNB $578.87 -2.87%
XRP $0.9654 -2.17%
SOL $73.16 -2.95%
TRX $0.3086 +0.33%
DOGE $0.0584 -2.90%
ADA $0.1501 -3.69%
BCH $206.43 -2.45%
LINK $9.02 -3.47%
HYPE $66.50 -4.76%
AAVE $108.12 -4.23%
SUI $0.7136 -2.99%
XLM $0.1368 -3.04%
ZEC $908.30 -5.03%
AAPL $353.54 +0.80%
AMZN $269.33 +2.98%
GOOGL $285.00 -0.02%
MSFT $509.66 -0.28%
META $617.91 -1.20%
NVDA $151.78 -7.32%
TSLA $384.61 -0.30%
SNDK $777.00 -8.48%
INTC $55.17 -3.11%
SPCX $144.12 +0.38%
MU $707.32 -5.76%
AMD $530.41 -0.35%
BTC $62,539.54 -3.76%
ETH $1,768.21 -2.95%
BNB $578.87 -2.87%
XRP $0.9654 -2.17%
SOL $73.16 -2.95%
TRX $0.3086 +0.33%
DOGE $0.0584 -2.90%
ADA $0.1501 -3.69%
BCH $206.43 -2.45%
LINK $9.02 -3.47%
HYPE $66.50 -4.76%
AAVE $108.12 -4.23%
SUI $0.7136 -2.99%
XLM $0.1368 -3.04%
ZEC $908.30 -5.03%
AAPL $353.54 +0.80%
AMZN $269.33 +2.98%
GOOGL $285.00 -0.02%
MSFT $509.66 -0.28%
META $617.91 -1.20%
NVDA $151.78 -7.32%
TSLA $384.61 -0.30%
SNDK $777.00 -8.48%
INTC $55.17 -3.11%
SPCX $144.12 +0.38%
MU $707.32 -5.76%
AMD $530.41 -0.35%

上市公司 Galmed 拟将 50% 现金储备配置于加密货币

2025-08-25 20:00:41

ChainCatcher 消息,据 PR Newswire 报道,美股上市生物制药公司 Galmed Pharmaceuticals Ltd. 宣布实施数字资产管理战略,公司计划将 1000 万美元(约占当前现金储备的 50%)用于数字资产投资。

公司已成立加密货币委员会,负责评估和监督加密货币相关投资活动。该策略将包括数字资产投资组合再平衡、参与流动性提供、质押收益和风险对冲策略等。

为执行该计划,Galmed 已与加密货币资产管理服务商 Tectona(TASE:TECT)签署意向书,由后者提供咨询和运营服务。

链捕手ChainCatcher提醒,请广大读者理性看待区块链,切实提高风险意识,警惕各类虚拟代币发行与炒作, 站内所有内容仅系市场信息或相关方观点,不构成任何形式投资建议。如发现站内内容含敏感信息,可点击,我们会及时处理。

app_icon
ChainCatcher 与创新者共建Web3世界